These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18520776)

  • 1. Neuronal hypertrophy in asymptomatic Alzheimer disease.
    Iacono D; O'Brien R; Resnick SM; Zonderman AB; Pletnikova O; Rudow G; An Y; West MJ; Crain B; Troncoso JC
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):578-89. PubMed ID: 18520776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.
    Iacono D; Resnick SM; O'Brien R; Zonderman AB; An Y; Pletnikova O; Rudow G; Crain B; Troncoso JC
    J Neuropathol Exp Neurol; 2014 Apr; 73(4):295-304. PubMed ID: 24607960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
    Iacono D; Markesbery WR; Gross M; Pletnikova O; Rudow G; Zandi P; Troncoso JC
    Neurology; 2009 Sep; 73(9):665-73. PubMed ID: 19587326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.
    Riudavets MA; Iacono D; Resnick SM; O'Brien R; Zonderman AB; Martin LJ; Rudow G; Pletnikova O; Troncoso JC
    Neurobiol Aging; 2007 Oct; 28(10):1484-92. PubMed ID: 17599696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study.
    Iacono D; Zandi P; Gross M; Markesbery WR; Pletnikova O; Rudow G; Troncoso JC
    Oncotarget; 2015 Jun; 6(16):14082-91. PubMed ID: 26101858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?
    Driscoll I; Troncoso J
    Curr Alzheimer Res; 2011 Jun; 8(4):330-5. PubMed ID: 21222594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
    Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
    Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.
    Price JL; Ko AI; Wade MJ; Tsou SK; McKeel DW; Morris JC
    Arch Neurol; 2001 Sep; 58(9):1395-402. PubMed ID: 11559310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal brain activity changes in asymptomatic Alzheimer disease.
    Codispoti KE; Beason-Held LL; Kraut MA; O'Brien RJ; Rudow G; Pletnikova O; Crain B; Troncoso JC; Resnick SM
    Brain Behav; 2012 May; 2(3):221-30. PubMed ID: 22741095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.
    Snowden SG; Ebshiana AA; Hye A; An Y; Pletnikova O; O'Brien R; Troncoso J; Legido-Quigley C; Thambisetty M
    PLoS Med; 2017 Mar; 14(3):e1002266. PubMed ID: 28323825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric Changes in Limbic Cortex and Planum Temporale in Patients with Alzheimer Disease.
    Kutová M; Mrzílková J; Riedlová J; Zach P
    Curr Alzheimer Res; 2018; 15(14):1361-1368. PubMed ID: 30289075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a neuropathology difference between mild cognitive impairment and dementia?
    Haroutunian V; Hoffman LB; Beeri MS
    Dialogues Clin Neurosci; 2009; 11(2):171-9. PubMed ID: 19585952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
    Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
    Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
    Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
    Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.